Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06659471 · ClinicalTrials.gov registry record · NA
Brief Title: a Clinical Study to Assess Gingivitis
A NA study of Gingival Diseases, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06659471 is a NA study of Gingival Diseases that has completed, run by Procter and Gamble. The registered enrollment target is 120 participants, above the 48-participant average among 4 other Gingival Diseases trials with a reported enrollment target (150% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06659471, a NA study of Gingival Diseases, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this learning clinical study is to evaluate the effects of formulation chemistry on gingivitis.
Conditions Studied
Interventions
- DRUG 0.76% Sodium Monofluorophosphate Dentifrice
- DRUG 0.454% Stannous Fluoride Dentifrice
Study Locations (1)
Nevada
- Silverstone Research - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-03-07 |
| Est. Completion | 2022-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06659471
The ClinicalTrials.gov registry entry for NCT06659471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 48-participant average among 4 other Gingival Diseases trials with a reported enrollment target (150% higher). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gingival Diseases appearing as the primary indexed condition, and to 2 interventions - of which 0.76% Sodium Monofluorophosphate Dentifrice is the first listed.
NCT06659471 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT06659471 about?
NCT06659471 is a clinical study titled "Brief Title: a Clinical Study to Assess Gingivitis". The objective of this learning clinical study is to evaluate the effects of formulation chemistry on gingivitis.
What is the current status of trial NCT06659471?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2022-03-07. Estimated completion is 2022-06-06.
What conditions does trial NCT06659471 study?
This clinical trial studies the following conditions: Gingival Diseases.
What interventions are being tested in trial NCT06659471?
The interventions under investigation include: 0.76% Sodium Monofluorophosphate Dentifrice (DRUG), 0.454% Stannous Fluoride Dentifrice (DRUG).
Who is sponsoring clinical trial NCT06659471?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06659471 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel Dental Gel as an Adjunct to Scaling and Root Planing
RECRUITING · NA
-
OCT Vibrography for Biomechanical Properties of Tissues
RECRUITING · NA
-
Effect of Using Placental Membranes on Healing and Post-op Pain After Gum Surgery
COMPLETED · NA
-
Pilot Efficacy Study to Treat Gingivitis
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.